抗体预测死亡率和肺功能趋势的抗体预测器在肌炎谱间歇性肺病中
Jennifer R Hannah1,2, Alexandra Lawrence3, Jennifer Martinovic3
1Department of Academic Rheumatology, King's College London, London, UK.
Rheumatology (Oxford, England)
|December 1, 2023
概括
自体抗体概况显著影响异常性炎症性肌肉炎相关间歇性肺病 (IIM-ILD) 的预后. 抗MDA5+和抗PL7+抗体与较高的死亡率有关,但抗MDA5+疾病的幸存者显示出有利的前景.
科学领域:
- 类风湿病学 类风湿病学
- 肺部病理学 肺部病理学
- 免疫学 免疫学 免疫学
背景情况:
- 与异形性炎症性肌肉炎相关的间歇性肺病 (IIM-ILD) 的预后受自身抗体样本的影响.
- 肌肉炎特异性抗体 (MSA) 在IIM-ILD和带有自身免疫特征的间歇性肺炎 (IPAF) -MSA的预后影响尚不清楚.
研究的目的:
- 调查IIM-ILD或IPAF-MSA患者的自身抗体概况和死亡率之间的关联.
- 确定血清学概况对IIM-ILD纵向肺功能变化的影响.
主要方法:
- 对430名患有IIM-ILD或IPAF-MSA的成年患者进行了回顾性队列研究.
- 分析基线特征,随访肺功能和死亡率数据.
- 采用了单变量和多变量考克斯比例危险模型,以及回归分析.
主要成果:
- 抗MDA5阳性 (MDA5+) 与短期死亡率 (前3个月) 的增加有关.
- 联合抗合成酶抗体,特别是抗Jo1+,与降低死亡率有关.
- 反PL7+抗体与增加的死亡率和肺功能缓慢下降有关.
- 抗MDA5+与前3年缓慢的FVC%改善有关.
结论:
- 抗MDA5+和抗PL7+自身抗体配置文件在IIM-ILD中具有更高的死亡风险.
- 患有抗MDA5+IIM-ILD的患者在最初的高风险时期幸存下来,表现出良好的预后.
- 特定的自身抗体对IIM-ILD的死亡率和肺功能轨迹有不同的影响.
关键词:
这是自抗体的自抗体.异形性炎症性肌肉病变 (Idiopathic Inflammatory Myopathies) 是一种异形性炎症性肌肉病变 (Idiopathic Inflammatory Myopathies) 的一种疾病.间歇性肺病 间歇性肺病死亡率 死亡率肌肉性肌肉性炎症 肌肉性肌肉炎这是一个渐进的过程.更多相关视频
10:21Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
Published on: September 20, 2024
464
14:48Visualizing Lung Cellular Adaptations during Combined Ozone and LPS Induced Murine Acute Lung Injury
Published on: March 21, 2021
5.1K
相关概念视频
Myasthenia Gravis: Diagnostic Tests
890
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
890
Myasthenia Gravis: Overview and Treatment
1.5K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.5K
Pneumonia III: Complications and Assessment
239
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
239
